What is Greenwich LifeSciences, Inc.'s Market Cap?

Greenwich LifeSciences, Inc.'s Market Cap is $230.2M, based on as-reported figures from SEC (XBRL) filings.

What is Greenwich LifeSciences, Inc.'s Enterprise Value?

Greenwich LifeSciences, Inc.'s Enterprise Value is $221.3M, based on as-reported figures from SEC (XBRL) filings.

What is Greenwich LifeSciences, Inc.'s Revenue (TTM)?

Greenwich LifeSciences, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Greenwich LifeSciences, Inc.'s Net Income (TTM)?

Greenwich LifeSciences, Inc.'s Net Income (TTM) is -$22.5M, based on as-reported figures from SEC (XBRL) filings.

What is Greenwich LifeSciences, Inc.'s Diluted EPS (TTM)?

Greenwich LifeSciences, Inc.'s Diluted EPS (TTM) is -1.53, based on as-reported figures from SEC (XBRL) filings.

What is Greenwich LifeSciences, Inc.'s Net Debt?

Greenwich LifeSciences, Inc.'s Net Debt is -$8.9M, based on as-reported figures from SEC (XBRL) filings.

Greenwich LifeSciences, Inc. (GLSI) Financial Statements

Greenwich LifeSciences, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00V6PT8D6

XNAS · usd

15.68▼ 0.22 (-1.38%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close15.90

Day's Range15.53 – 16.25

52-Week Range7.78 – 34.15

Volume58.0K

Avg Volume121.4K

Share Statistics

Shares Outstanding

Employees8

ExchangeXNAS

Listed2020-09-25

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Greenwich LifeSciences, Inc. (GLSI)

What is Greenwich LifeSciences, Inc.'s Market Cap?: Greenwich LifeSciences, Inc.'s Market Cap is $230.2M, based on as-reported figures from SEC (XBRL) filings.
What is Greenwich LifeSciences, Inc.'s Enterprise Value?: Greenwich LifeSciences, Inc.'s Enterprise Value is $221.3M, based on as-reported figures from SEC (XBRL) filings.
What is Greenwich LifeSciences, Inc.'s Revenue (TTM)?: Greenwich LifeSciences, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Greenwich LifeSciences, Inc.'s Net Income (TTM)?: Greenwich LifeSciences, Inc.'s Net Income (TTM) is -$22.5M, based on as-reported figures from SEC (XBRL) filings.
What is Greenwich LifeSciences, Inc.'s Diluted EPS (TTM)?: Greenwich LifeSciences, Inc.'s Diluted EPS (TTM) is -1.53, based on as-reported figures from SEC (XBRL) filings.
What is Greenwich LifeSciences, Inc.'s Net Debt?: Greenwich LifeSciences, Inc.'s Net Debt is -$8.9M, based on as-reported figures from SEC (XBRL) filings.